Formula Grant IN2025028
- This $301,818,364 federal Project Grant award from the Federal Transit Administration's (FTA) Capital Investment Grants program (CFDA 20.500) will fund the construction of Indianapolis Public Transportation Corporation's (Indygo) 24-mile Blue Line bus rapid transit (BRT) system. The project includes the design, right-of-way acquisition, and construction of 30 BRT stations, the purchase of 18 new 60-foot articulated clean diesel vehicles, and the installation of transit signal priority and...
- This $1,250,000 Project Grant awarded by the U.S. Department of Transportation's Federal Transit Administration (CFDA 20.534 - Community Project Funding Congressionally Directed Spending) will fund stormwater modernization and separation activities for a portion of the Indianapolis Public Transportation Corporation's (Indygo) third Bus Rapid Transit (BRT) line, the Blue Line. The stormwater infrastructure updates will reduce flooding and improve public health and safety along the future Blue...
- This $20,336,500 federal Project Grant award from the Federal Transit Administration's Capital Investment Grants program (CFDA 20.500) will support the design, program management, and construction management activities for the Indianapolis Public Transportation Corporation's (Indygo) Blue Line bus rapid transit (BRT) project. The Blue Line will replace and improve Indygo's existing Route 8, which is one of the highest ridership and most productive routes in the system. The project aims to...
- This federal Formula Grant award, provided by the Federal Transit Administration (FTA) under the Buses and Bus Facilities Formula, Competitive, and Low or No Emissions Programs (CFDA 20.526), will fund the construction of 16 stations and professional services related to the development of the Indianapolis Public Transportation Corporation's (Indygo) Blue Line bus rapid transit (BRT) project. The $6,365,966 grant, awarded on April 8, 2025, will support this project that is expected to improve...
- This $9,269,619 Federal Transit Formula Grant (CFDA 20.507) awarded by the Federal Transit Administration (FTA) will be used by the Indianapolis Public Transportation Corporation (Indygo) to purchase five 60-foot buses for the new Blue Line bus rapid transit (BRT) project in Indianapolis, Indiana. The Blue Line is intended to replace and improve the existing Route 8 local bus service, which is one of Indygo's highest ridership and most productive routes. The project is expected to provide more...
- This federal Project Grant award of $69,055,420 was provided by the Federal Transit Administration (FTA) under the Buses and Bus Facilities Formula, Competitive, and Low or No Emissions Programs (CFDA 20.526). The grant funding will be used by the Indianapolis Public Transportation Corporation (Indygo) to build an operational center to address current and future fleet needs, recruit and train employees on low-emission vehicle technologies, and purchase 20 diesel-electric hybrid buses for fleet...
- This federal Formula Grant award, provided by the U.S. Department of Transportation's Federal Transit Administration (FTA) under the Enhanced Mobility of Seniors and Individuals with Disabilities program (CFDA 20.513), will provide $2,422,878 to the Indianapolis Public Transportation Corporation (IndyGo) and its sub-recipients. The funding will be utilized to maintain safe and reliable transit services in the Indianapolis urbanized area, including the purchase of 30-foot buses and taxi...
- The Federal Transit Administration awarded a $134.5 million Project Grant to the Indpls Public Transportation Corporation (Indygo) on August 24, 2021 through the Capital Investment Grants Program (CFDA 20.500). The grant will fund construction of the Purple Line Bus Rapid Transit project in Indianapolis, Indiana through March 30, 2027. Specifically, the grant will support design, right-of-way acquisition, and construction of 9.9 miles of exclusive bus lanes and 18 new stations. It will also fund...
- This $2,038,765 federal Formula Grant award from the Federal Transit Administration (CFDA 20.526 - Buses and Bus Facilities Formula, Competitive, and Low or No Emissions Programs) will provide funding to the Indianapolis Public Transportation Corporation (Indygo) and its sub-recipients. The grant will support Indygo's purchase of 30-foot buses and taxi vouchers, as well as the sub-recipients' acquisition of expansion and replacement vehicles. These investments are intended to help Indygo and its...
- The Federal Transit Administration (FTA) awarded a $708,333 Project Grant under the Metropolitan Transportation Planning and State and Non-Metropolitan Planning and Research program (CFDA 20.505) to the Indianapolis Public Transportation Corporation (Indygo), the primary public transit provider serving Indianapolis and surrounding counties. The grant funding will be used to complete the design engineering and environmental review process to improve and bring bus stops into ADA compliance...
This Federal Formula Grant award of $27,336,538.00, provided by the Federal Transit Administration (FTA) under the National Infrastructure Investments (CFDA 20.933) program, will support safety upgrades, street modernization, and transit signal priority (TSP) improvements along a section of historic East Washington Street in Indianapolis, Indiana. The key project activities include upgrading sidewalks, adding new crosswalks, providing ADA-compliant curb ramps, installing transit signal priority technology, and adjusting the road configuration to add dedicated bus rapid transit (BRT) lanes. These infrastructure enhancements are being implemented in coordination with the IndyGo Blue Line BRT project that runs along the same corridor, allowing for cost savings through combined construction. The expected outcomes are increased safety, transit efficiency, and accessibility for riders of the IndyGo Blue Line BRT service, as well as improved safety and accessibility for residents, employees, and visitors in the project area. The award period runs from September 24, 2025, through the ultimate completion date of December 31, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $21.9m | 9/24/25 |